financetom
Business
financetom
/
Business
/
Market Chatter: Dissident To Fight Board Vote Delay In Court After Parkland, Sunoco Ink US$9.1 Billion Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Dissident To Fight Board Vote Delay In Court After Parkland, Sunoco Ink US$9.1 Billion Deal
May 26, 2025 1:26 AM

02:40 PM EDT, 05/05/2025 (MT Newswires) -- Parkland Corp.'s ( PKIUF ) biggest shareholder is going to court after the Calgary company announced a US$9.1-billion takeover by Sunoco LP ( SUN ) and delayed a meeting where it was to face down investors pushing for a boardroom overhaul, The Canadian Press is reporting Monday.

It noted a showdown had been set to take place in Calgary on Tuesday, with shareholders voting on competing director nominee slates put forward by Parkland's management and by Simpson Oil, which owns just under 20% of the Canadian fuel retailer and refiner's shares. Parkland and Cayman Islands-based Simpson have been at odds over the fuel refiner and retailer's performance and governance for about a year.

Tuesday's report noted Parkland's meeting has been rescheduled to June 24, when Parkland shareholders are to vote on a cash-and-stock deal with Dallas-based Sunoco ( SUN ) that would create the largest independent fuel distributor in the Americas.

Simpson says it has applied to the Alberta Court of King's Bench to hold the annual meeting as planned, calling the delay a "deplorable tactic" and a bid to "cling to control" by the existing board. Simpson says no action should have been taken under a new board of directors supported by shareholders was in place. "Delaying the meeting and pushing forward with any transaction ahead of board transition represents a clear breach of fiduciary duty -- an obvious attempt to cling to power and sidestep shareholder will," Simpson said in a statement Monday.

Simpson is calling on all 11 incumbent Parkland directors to resign immediately, including executive chair Mike Jennings.

The cash-and-stock deal between Parkland and Sunoco ( SUN ) announced Monday requires shareholder and regulatory approval and also has to be cleared under the Investment Canada Act. The U.S. company has committed to maintain a Canadian headquarters in Calgary, significant employment in Canada and investment in Parkland's refinery in Burnaby, B.C.

"This combination with Sunoco ( SUN ) provides Parkland's shareholders with the highest value and the greatest proceeds, while also affirming Sunoco's ( SUN ) and Parkland commitment to Canada, a country that has played a vital role in our combined history," said outgoing Parkland chief executive Bob Espey. "Sunoco ( SUN ) is a strong organization and clearly the right choice for Parkland."

Espey, who had been at the helm for 17 years, announced earlier this month that he would step down before year-end.

Under shareholder pressure, Parkland said in March it would review options to boost its share price, including a sale of the entire company, an action it had earlier said was unnecessary.

As part of the deal, Sunoco ( SUN ) intends to form a new publicly traded company named SUNCorp LLC that will hold limited partnership units of Sunoco ( SUN ) that are economically equivalent to Sunoco's ( SUN ) publicly traded common units.

Parkland shareholders will receive 0.295 SUNCorp units and $19.80 for each Parkland share. Parkland shareholders may also elect to receive $44 per Parkland share in cash or 0.536 SUNCorp units for each Parkland share, subject to limits. The cash-and-stock deal also includes Parkland's assumed debt.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 39.05, Change: +2.77, Percent Change: +7.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved